Business Wire

PVH-CORP.

28.3.2022 09:02:06 CEST | Business Wire | Press release

Share
Fourth Tommy Hilfiger Fashion Frontier Challenge Calls on Social Entrepreneurs Accelerating Inclusivity in Fashion

Tommy Hilfiger, which is owned by PVH Corp. [NYSE: PVH], is pleased to announce that applications for the fourth edition of the Tommy Hilfiger Fashion Frontier Challenge are open. The global program echoes Tommy Hilfiger’s sustainability vision to Waste Nothing and Welcome All, amplifying and supporting new voices in the world of social entrepreneurship who are shaping scalable and disruptive innovations to create a more inclusive future of fashion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220328005210/en/

In line with Tommy Hilfiger’s commitments towards inclusion, diversity, and acknowledging the gap in equity and equal opportunities, individuals from historically underrepresented communities, including Black, Indigenous, People of Color (BIPOC), people with disabilities and women, are strongly encouraged to apply this year. Applications can be submitted by April 29, 2022, through https://platform.younoodle.com/competition/th_fashion_frontier_challenge_2022 .

“The Tommy Hilfiger Fashion Frontier Challenge aims to bring together entrepreneurs from all walks of life, investing knowledge and resources to unlock the unique power of their innovations,” said Tommy Hilfiger. “As an entrepreneur myself, I always wanted to build a global lifestyle brand that is inclusive of everyone — a philosophy that continues to live through this challenge. I truly believe that by coming together we can drive a future of meaningful and long-lasting change.”

The following prizes will be awarded to the winners to support their business idea:

  • A total of €200,000 split between two winners
  • Additional €15,000 prize for being elected the “Audience’s Favorite Vote”
  • A year-long mentorship with Tommy Hilfiger’s internal global experts
  • A year-long INSEAD mentorship and course

Tommy Hilfiger is inviting fans of the brand to participate in the first phase of the challenge as Digital Judges. They will help the brand narrow down all applications to the Top 50. Interested applicants are invited to apply until April 20, 2022, through https://platform.younoodle.com/competition/consumer_vote_tommy_hilfiger_fashion_frontier_challenge_2022 .

The top 50 applicants will then be narrowed down to six finalists through an internal procedure. Each finalist will be invited to further develop their business plan with the support of dedicated Tommy Hilfiger and external experts ahead of the final event. With training from an experienced pitch coach, each finalist will then present their concept to a jury panel and internal Tommy Hilfiger associate audience at the global Tommy Hilfiger Fashion Frontier Challenge final event in early 2023.

“At Tommy Hilfiger, we want to work together with communities to drive innovation, inclusivity, and diversity to drive long-lasting change,” said Martijn Hagman, CEO, Tommy Hilfiger Global and PVH Europe. “As we kick-off for the fourth Tommy Hilfiger Fashion Frontier Challenge , we really look forward to seeing what ideas come to light that will support communities and help shape the future of fashion.”

Since its inception in 2018, the Tommy Hilfiger Fashion Frontier Challenge has awarded €550,000 to support global entrepreneurs bring their innovative ideas to life, so they can make real changes to their communities. The third edition winners include Lalaland, a Netherlands-based platform that uses artificial intelligence to generate customized and inclusive synthetic models of different ethnicities and UZURI K&Y, a Rwandan-based eco-friendly shoe brand that uses recycled car tires from sub-Saharan Africa and employs local youth. Clothes to Good, a South African-based social enterprise that creates micro-business opportunities and jobs for people with disabilities through textile recycling, was awarded the Audience Favorite vote. More information about Tommy Hilfiger’s sustainability journey, which is powered by PVH’s Forward Fashion strategy can be found on https://global.tommy.com/en_int/about-us-corporate-sustainability .

More information about the Tommy Hilfiger Fashion Frontier Challenge , including how to apply, is available here: https://responsibility.pvh.com/tommy/fashion-frontier-challenge/ .

Friends and followers of the brand are invited to join the conversation on social media using #TommyHilfiger, and @TommyHilfiger.

About Tommy Hilfiger
TOMMY HILFIGER is one of the world’s most recognized premium lifestyle brands, uplifting and inspiring consumers since 1985. Colliding the classic with the new to light up what's next, the brand boldly mixes prep style and Americana heritage with fresh perspectives drawn from pop culture to design memorable products and collections. Under Mr. Hilfiger’s vision, TOMMY HILFIGER captures the playful alchemy needed to drive innovative and immersive consumer experiences. At the heart of the brand is the vision to Waste Nothing and Welcome All, an unwavering commitment to sustainability, inclusivity, diversity, and circularity that powers teams to create a better fashion industry.

Global retail sales of TOMMY HILFIGER products were almost $7 billion in 2020. Across the TOMMY HILFIGER and TOMMY JEANS lifestyles, the collections include mens, womens and kids; footwear and accessories; close to body; and a range of license product lines including eyewear, watches and fragrance. Part of PVH Corp., the Tommy Hilfiger Group is powered by more than 16,000 associates worldwide — boasting an extensive distribution network spanning 100 countries and more than 2,000 retail stores, including its largest global flagship store at tommy.com.

About PVH Corp.
PVH is one of the world’s largest and most admired fashion companies, connecting with consumers in over 40 countries. Our global iconic brands include Calvin Klein and TOMMY HILFIGER . Our 140-year history is built on the strength of our brands, our team and our commitment to drive fashion forward for good. That's the Power of Us. That’s the Power of PVH.

Follow us on Facebook , Instagram , Twitter and LinkedIn .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye